Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem Cells

  1. Naka Hattori1,
  2. Tetsuya Abe1,
  3. Naoko Hattori1,
  4. Masako Suzuki1,
  5. Tomoki Matsuyama2,
  6. Shigeo Yoshida2,
  7. En Li3,4, and
  8. Kunio Shiota1,5
  1. 1 Laboratory of Cellular Biochemistry, Animal Resource Sciences / Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan
  2. 2 Plant Functions Laboratory, RIKEN (The Institute of Physical and Chemical Research), Wako, Saitama 351-0198, Japan
  3. 3 Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA

Abstract

Many CpG islands have tissue-dependent and differentially methylated regions (T-DMRs) in normal cells and tissues. To elucidate how DNA methyltransferases (Dnmts) participate in methylation of the genomic components, we investigated the genome-wide DNA methylation pattern of the T-DMRs with Dnmt1-, Dnmt3a-, and/or Dnmt3b-deficient ES cells by restriction landmark genomic scanning (RLGS). Approximately 1300 spots were detected in wild-type ES cells. In Dnmt1-/- ES cells, additional 236 spots emerged, indicating that the corresponding loci are methylated by Dnmt1 in wild-type ES cells. Intriguingly, in Dnmt3a-/-Dnmt3b-/- ES cells, the same 236 spots also emerged, and no additional spots appeared differentially. Therefore, Dnmt1 and Dnmt3a/3b share targets in CpG islands. Cloning and virtual image RLGS revealed that 81% of the RLGS spots were associated with genes, and 62% of the loci were in CpG islands. By contrast to the previous reports that demethylation at repeated sequences was severe in Dnmt1-/- cells compared with Dnmt3a-/-Dnmt3b-/- cells, a complete loss of methylation was observed at RLGS loci in Dnmt3a-/-Dnmt3b-/- cells, whereas methylation levels only decreased to 16% to 48% in the Dnmt1-/- cells. We concluded that there are CpG islands with T-DMR as targets shared by Dnmt1 and Dnmt3a/3b and that each Dnmt has target preferences depending on the genomic components.

Footnotes

  • Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.2431504. Article published online before print in August 2004.

  • 4 Present address: Novartis Institute for Biomedical Research, Cambridge, MA 02139.

  • 5 Corresponding author. E-MAIL ashiota{at}mail.ecc.u-tokyo.ac.jp; FAX 81-3-5841-8189.

    • Accepted June 29, 2004.
    • Received February 9, 2004.
| Table of Contents

Preprint Server